1. Damage‐Associated Molecular Patterns in the Course of Lung Cancer – A Review
   M. Łagiedo et al, 2015, Scandinavian Journal of Immunology CrossRef
2. Ursolic Acid Reverses the Chemoresistance of Breast Cancer Cells to Paclitaxel by Targeting MiRNA-149-5p/MyD88
   Fenfen Xiang et al, 2019, Frontiers in Oncology CrossRef
3. MiRNA-149 modulates chemosensitivity of ovarian cancer A2780 cells to paclitaxel by targeting MyD88
   Yueping Zhan et al, 2015, Journal of Ovarian Research CrossRef
4. Chemotherapeutic paclitaxel and cisplatin differentially induce pyroptosis in A549 lung cancer cells via caspase-3/GSDME activation
   Cheng-cheng Zhang et al, 2019, Apoptosis CrossRef
5. Increased expression of MyD88 and association with paclitaxel resistance in breast cancer
   Fenfen Xiang et al, 2016, Tumor Biology CrossRef
6. A novel immunogenic cell death signature for the prediction of prognosis and therapies in glioma
   Jianhua Zhang et al, 2023, PeerJ CrossRef
7. Recent Advances in Elucidating Paclitaxel Resistance Mechanisms in Non-small Cell Lung Cancer and Strategies to Overcome Drug Resistance
   Hongmei Cui et al, 2020, Current Medicinal Chemistry CrossRef
8. Synthesis of small molecules targeting paclitaxel-induced MyD88 expression in triple-negative breast cancer cell lines
   Khor Poh Yen et al, 2021, Bioorganic & Medicinal Chemistry CrossRef
9. Mechanisms of resistance to chemotherapy in non-small cell lung cancer
   Hye-Young Min et al, 2021, Archives of Pharmacal Research CrossRef
10. An EHMT2/NFYA-ALDH2 signaling axis modulates the RAF pathway to regulate paclitaxel resistance in lung cancer
    Wenjing Wang et al, 2022, Molecular Cancer CrossRef